EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
May 1, 2011, 00:00
10.1016/j.jval.2011.02.060
https://www.valueinhealthjournal.com/article/S1098-3015(11)00199-9/fulltext
Title :
EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00199-9&doi=10.1016/j.jval.2011.02.060
First page :
A10
Section Title :
Evolving Concepts in Outcomes Research
Open access? :
No
Section Order :
6